
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Simone de Leve, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
Simone de Leve, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
Showing 1-25 of 81 citing articles:
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 636
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 636
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Detlev Boison, Gennady G. Yegutkin
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 582-596
Open Access | Times Cited: 265
Detlev Boison, Gennady G. Yegutkin
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 582-596
Open Access | Times Cited: 265
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Gürcan Günaydın
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 144
Gürcan Günaydın
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 144
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 73
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 73
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg, Sheila Spada, Nils-Petter Rudqvist, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 465-478
Open Access | Times Cited: 107
Erik Wennerberg, Sheila Spada, Nils-Petter Rudqvist, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 465-478
Open Access | Times Cited: 107
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside
Łukasz Mateuszuk, Roberto Campagna, Barbara Kutryb-Zając, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114019-114019
Open Access | Times Cited: 73
Łukasz Mateuszuk, Roberto Campagna, Barbara Kutryb-Zając, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114019-114019
Open Access | Times Cited: 73
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Hyaluronic Acid: Known for Almost a Century, but Still in Vogue
Anna Lierová, Jitka Kašparová, Alžběta Filipová, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 838-838
Open Access | Times Cited: 51
Anna Lierová, Jitka Kašparová, Alžběta Filipová, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 838-838
Open Access | Times Cited: 51
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 47
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 47
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 44
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 44
ENPP1 Immunobiology as a Therapeutic Target
Borja Ruiz‐Fernández de Córdoba, Rafael Martínez‐Monge, Fernando Lecanda
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2184-2193
Open Access | Times Cited: 33
Borja Ruiz‐Fernández de Córdoba, Rafael Martínez‐Monge, Fernando Lecanda
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2184-2193
Open Access | Times Cited: 33
The Clinical Significance of CD73 in Cancer
Niklas Bach, Riekje Winzer, Eva Tolosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11759-11759
Open Access | Times Cited: 31
Niklas Bach, Riekje Winzer, Eva Tolosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11759-11759
Open Access | Times Cited: 31
Review immune response of targeting CD39 in cancer
Yao Liu, Zhongliang Li, Xiaoguang Zhao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Yao Liu, Zhongliang Li, Xiaoguang Zhao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Purinergic Signaling in the Hallmarks of Cancer
Anaí del Rocío Campos‐Contreras, Mauricio Dı́az-Muñoz, Francisco G. Vázquez‐Cuevas
Cells (2020) Vol. 9, Iss. 7, pp. 1612-1612
Open Access | Times Cited: 70
Anaí del Rocío Campos‐Contreras, Mauricio Dı́az-Muñoz, Francisco G. Vázquez‐Cuevas
Cells (2020) Vol. 9, Iss. 7, pp. 1612-1612
Open Access | Times Cited: 70
Ionizing radiation effects on the tumor microenvironment
Luigi Portella, Stefania Scala
Seminars in Oncology (2019) Vol. 46, Iss. 3, pp. 254-260
Closed Access | Times Cited: 63
Luigi Portella, Stefania Scala
Seminars in Oncology (2019) Vol. 46, Iss. 3, pp. 254-260
Closed Access | Times Cited: 63
Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment
Anna M. Chiarella, Yun Kyoung Ryu, Gulam A. Manji, et al.
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 731-750
Closed Access | Times Cited: 52
Anna M. Chiarella, Yun Kyoung Ryu, Gulam A. Manji, et al.
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 731-750
Closed Access | Times Cited: 52
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Jasmeet Kaur, Sanchit Dora
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Jasmeet Kaur, Sanchit Dora
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
Juliana H. Azambuja, Nils Ludwig, Elizandra Braganhol, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5698-5698
Open Access | Times Cited: 47
Juliana H. Azambuja, Nils Ludwig, Elizandra Braganhol, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5698-5698
Open Access | Times Cited: 47
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
Hidenori Tsukui, Hisanaga Horie, Koji Koinuma, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Hidenori Tsukui, Hisanaga Horie, Koji Koinuma, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
Dana Piovesan, Joanne B.L. Tan, Annette Becker, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 6, pp. 948-959
Open Access | Times Cited: 25
Dana Piovesan, Joanne B.L. Tan, Annette Becker, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 6, pp. 948-959
Open Access | Times Cited: 25
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models
Jian Ye, Nicholas W Gavras, David C Keeley, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006842-e006842
Open Access | Times Cited: 15
Jian Ye, Nicholas W Gavras, David C Keeley, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006842-e006842
Open Access | Times Cited: 15
Radiation-induced Adaptive Response: New Potential for Cancer Treatment
C. Norman Coleman, Iris Eke, Adeola Y. Makinde, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 22, pp. 5781-5790
Open Access | Times Cited: 36
C. Norman Coleman, Iris Eke, Adeola Y. Makinde, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 22, pp. 5781-5790
Open Access | Times Cited: 36